Mathew Blackman
Stock Analyst at Stifel
(3.68)
# 748
Out of 4,944 analysts
61
Total ratings
48.84%
Success rate
9.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $7.77 | -9.85% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $11.13 | +178.53% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $257.38 | +23.55% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $11.92 | +109.73% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $15.10 | +65.56% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $308.68 | -5.08% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $62.79 | +49.71% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $14.11 | +70.09% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.33 | +125.56% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $79.96 | +25.06% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $15.80 | +1.27% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.73 | +13.05% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $7.77
Upside: -9.85%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $11.13
Upside: +178.53%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $257.38
Upside: +23.55%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $11.92
Upside: +109.73%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $15.10
Upside: +65.56%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $308.68
Upside: -5.08%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $62.79
Upside: +49.71%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $14.11
Upside: +70.09%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.33
Upside: +125.56%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $79.96
Upside: +25.06%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $15.80
Upside: +1.27%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.73
Upside: +13.05%